- Home
- IMNM vs HE Comparison
IMNM vs HE Comparison
Compare IMNM & HE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMNM | HE |
|---|---|---|
| Founded | 2006 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | IMNM | HE |
|---|---|---|
| Price | $21.92 | $15.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | ★ $32.10 | $12.67 |
| AVG Volume (30 Days) | 1.0M | ★ 2.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.06 | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | $9,041,000.00 | ★ $3,219,850,000.00 |
| Revenue This Year | N/A | $12.61 |
| Revenue Next Year | $11.53 | $2.04 |
| P/E Ratio | ★ N/A | $32.88 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.15 | $9.06 |
| 52 Week High | $27.65 | $17.33 |
Technical Indicators
Market Signals| Indicator | IMNM | HE |
|---|---|---|
| Relative Strength Index (RSI) | 43.67 | 49.66 |
| Support Level | $18.98 | $10.56 |
| Resistance Level | $22.57 | $17.33 |
| Average True Range (ATR) | 1.18 | 0.51 |
| MACD | -0.31 | -0.23 |
| Stochastic Oscillator | 15.51 | 16.44 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.